Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
| Status: | Completed |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 40 - Any |
| Updated: | 2/21/2019 |
| Start Date: | September 2015 |
| End Date: | September 2016 |
A Phase 3, 12-week, Randomized, Double-blind Placebo-controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
The purpose of this study is to measure the effectiveness and safety of TD 4208, an
investigational drug being developed to treat people with moderate to very severe COPD,
compared to placebo, a treatment without activity.
investigational drug being developed to treat people with moderate to very severe COPD,
compared to placebo, a treatment without activity.
Inclusion Criteria:
- Subject is a male or female subject 40 years of age or older
Exclusion Criteria:
- Females who are pregnant, lactating, breast-feeding or planning to become pregnant
during the study
We found this trial at
1
site
Easley, South Carolina 29640
Principal Investigator: Andras Koser, MD
Phone: 864-307-1300
Click here to add this to my saved trials
